SINUVA® Mometasone Furoate 1350 mcg Implant for Nasal Polyps
USAMP#54988164SKU: 10599000301SINUVA®
License Required
Product Spotlight
- SINUVA® Mometasone Furoate 1350 mcg Implant is a clinically proven, steroid-releasing implant designed specifically for adults over 18 who have undergone ethmoid sinus surgery and are suffering from recurrent nasal polyps.
- This innovative treatment option provides targeted, localized delivery of mometasone furoate directly to the sinus tissue, helping to reduce polyp size and alleviate associated nasal congestion and obstruction.
- Manufactured by Intersect ENT Inc, SINUVA® is a minimally invasive option that offers an alternative to systemic steroids or repeat surgical procedures for patients with challenging nasal polyp conditions.
